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Similarities in morphology and in glandular and squamous differentiation patterns amongst syringomas of
the breast nipple and of the skin suggest a common nature, but the origin of nipple syringoma remains
undefined.Usingtripleimmunofluorescenceanalysis,wefoundthatcellsimmunopositiveforbasalkeratins
K5 and 14 undergo differentiation into glandular and squamous cell lineages. Both tumour types expressed
K10, indicative of squamous lineage, but there were specific differences in their glandular lineage. In
contrasttothebreastnipplesyringoma,whichexpressedglandularkeratinsK8/18/19,syringomaoftheskin
only expressed the glandular keratin K19. Therefore, syringomas of the breast nipple and of the skin
resemble glandular lineages of the breast nipple duct or eccrine duct epithelium, respectively. From these
results we conclude that K5/14-positive cells of the breast nipple ducts are the putative cells of origin for
syringomas of the nipple, which highlights the organotypic glandular differentiation potential.
S
yringomas of the nipple (or ‘‘syringomatous adenomas of nipple’’ as a formal entity) are rare tumours
characterised by well-developed glands intimately admixed with solid nests of squamous differentiation
that are immersed in a collagenous stroma
1–5. Since the first description of syringomas of the nipple, their
morphological similarities to syringomatous tumours of the skin
6–9 have led researchers to propose a common
histogenesis for syringomatous adenoma of the nipple and the skin
4. Given their differentiation towards struc-
tures of the eccrine sweat gland duct
10, the histogenetic relationship between syringoma of the skin to eccrine
sweat gland ducts has been clearly demonstrated. As eccrine sweat glands are occasionally found in the dermis of
the nipple, it was theorised that syringoma of the nipple might also have its origins in sweat gland ducts.
To test this hypothesis, we investigated syringoma of the breast nipple and the skin using multiple immuno-
fluorescence staining methods
11,12. Through simultaneous mapping of basal (K5/14), glandular (K7/8/18/19)
and squamous (K10) keratins along with discriminatory myoepithelial markers in situ, we determined various
immunophenotypes and outlined different cell lineages. These results were used to construct lineage trees in a
novelmannercomparedtoordinaryimmunohistology.Withthisapproach,weconcludedthatsyringomasofthe
nipple derive from K5/14-positive breast epithelial cells from large ducts rather than nipple sweat gland ducts,
which reflects the organotypic glandular differentiation potential.
Results
In this study, we analysed 10 cases of syringoma of the nipple and 16 cases of typical syringoma of the skin with
conventional immunohistological and triple immunofluorescence staining methods. Tumour cell subtypes from
both syringomas were compared with their normal counterparts based on the epithelial hierarchy of normal
human breast epithelium
13–15 and eccrine gland ducts
10. Glandular cell phenotype was identified with antibodies
against keratins K8/18/19
10,16. Epidermal differentiation-specific antibody to keratin K10 was regarded as a
surrogate marker for squamous differentiation
17. Myoepithelial cells were probed with antibodies to smooth
muscle actin (SMA)
18, and antibodies to basal keratins K5/14 were used as references.
SyringomaofthebreastnipplecontainsK5/14-positivecellswithK8/18-positiveglandularandK10–positive
squamous differentiation. Breast nipple syringomas were composed of open tubules with rounded, ovoid or
elongated lumens. These syringomas also had cord-like structures (trabecular and solid), which were often
angulated, comma-like or tadpole-like in shape (Fig. 1a). These structures were composed of cuboidal to
polygonal cells with bland nuclei (Fig. 1b). The epithelial structures regularly contained lumens with flattened
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observed. The percentage of epithelial structures with epidermoid or
squamous differentiations ranged from moderate to abundant.
Formation of keratinous microcysts or horn pearls was observed.
A myoepithelial layer was not found in HE stained sections.
Abundant stroma consisted of densely collagenous to spindle-cell
cellular fibromatosis-like stroma.
Tracingcelllineagesinsyringomatousadenomaofthenipple.The
most characteristic feature of these tumours was the extensive
expression of basal keratins K5/14 in nearly all tumour cells
(Fig. 1c). We also observed varying focal expression of glandular
keratins K8/18, which were regarded in this context as a surrogate
markerforglandulardifferentiation(Fig.1d).Keratin 19 was variably
expressed in these lesions and showed a similar expression pattern as
K8/18, whereas syringoma of the skin expressed only K19. Epidermal
differentiation-specific keratin K10, which is regarded as a surrogate
marker for squamous differentiation, was moderately to abundantly
expressed in all cases. Myoepithelial differentiation, as defined by the
co-expression of basal keratins K5 and K14 with the myoepithelial
marker SMA
18, was found only in two cases.
Togainbetterinsightintothenatureandstateofdifferentiationof
these lesions, we performed triple staining with antibodies against
basal(K5/14),glandular(K8/18)andsquamous(K10)keratinsalong
with antibodies against the myoepithelial marker SMA. Basal kera-
tins K5 and/or K14 were used as references. A number of cords and
bilayered tubules contained tumour cells that only expressed the
basal keratins K5/14 (Figs 1, 2); in one tumour, more than 50% of
the tumour cells were K5/14-positive cells. Two lineages of differ-
entiationwereobservedintheselesions:(i)glandularand(ii)squam-
ous differentiation with the typical distribution of cell subtypes. At
the periphery of many epithelial structures, one or several layers of
K5/14-positivecells(Fig.2,asterisk)werefound,whichblendedwith
the inner layers of the K10-positive squamous cells or the K8/18-
positive glandular cells (Figs 1d and 2a,b).
Differentiation occurred gradually with the sequential expression
of K5/14, then K5/14 and K8/18 (intermediary glandular cells) and
finally K8/18-positive glandular cells (tailed arrow). In contrast,
squamous differentiation presented with sequential alternative
expression of K5/14 and squamous keratin K10 (Fig. 2, arrow).
Thus, glandular and squamous differentiation could be assumed to
result from K5/14-positive progenitor cells. During this process,
basal keratins K5 and/or K14 were eventually downregulated, and
the lineage specific marker was solely expressed. These findings
excluded an origin of the squamous lineage from myoepithelial or
glandular cells, in contrast to suggestions from the literature
19–22.
Figure 1 | Syringoma of the nipple. (a) and (b) HE staining shows the
typical pattern of this tumour. (a) Solid cord-like epithelial proliferation
withangulatedorcomma-likeshapewithinfiltrationofthenipplesmooth
muscle cells. The tumour contained keratinous cysts in the upper part. (b)
Comma-likeepithelialproliferationofmonotonouscellswithblandnuclei
at a higher magnification. (c) Nearly all tumour cells are K5-positive. (d)
Typical expression of the lineage specific keratins, K5 (pink, asterisks)
K8/18 (red) and K10 (green) in the tumour cells. Scale bars, 100 mm.
Figure 2 | Syringomatous adenoma of the nipple. (a) and (b) Triple
immunofluorescence labelling for basal K5 (pink), glandular K8/18 (red)
and squamous K10 (green) keratins in tumour cells. The cord-like
structures reveal many cells that only expressed K5, which are observed in
theperiphery(asterisks).Theinnercellsdisplayagradualdifferentiationto
eitherglandular(8/18;red)orsquamous(K10;green)differentiation.This
lineage differentiation is characterised by a gradual transition from K5-
positive cells to the lineage marker (in this case K8/18) with sequential
expression of K5 and K8/18 with intermediary glandular cells (K51;
K8/181; arrows) and finally glandular cells (only K8/181; tailed arrows).
A similar gradual evolution is shown in these figures with a sequential
expression of K5 and K10. These figures provide evidence that glandular
and squamous cell differentiation evolved from K5-positive cells.
www.nature.com/scientificreports
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of these two lineage markers or with additional basal keratins in
the same cells were occasionally observed. Orderly lineage differ-
entiation appeared to be lost in these cells. Earlier reports described
myoepithelial differentiation as a constitutive feature of syringomas
of the nipple
23–26. However, our study showed that myoepithelial
differentiation was not a constitutive feature. Likewise, myofibro-
blasts of the desmoplastic stroma potentially contained numerous
SMA-positive myofibroblasts that were intermittently observed near
the tumour sheets, which could be misinterpreted as myoepithelial
cells (not shown). These cells did not express K5/14, which was in
accord with a previous study on myofbroblasts
18.
Three syringomas of the nipple in our series were associated with
sclerosing lesions (adenomatous adenoma, sclerosing adenosis, and
sclerosing papilloma). In these cases, transitions from sclerosing
adenosis and adenomatous adenoma to a classical pattern of syrin-
goma were observed (not shown).
Syringoma of the skin derives from K5/14 target cells of the
eccrine gland duct. In this study, 16 cases of syringomas of the
skin were analysed and classified according to the WHO criteria
27.
They represented well-circumscribed nodules in the upper dermis
that ranged from 1.5 mm to 8 mm in diameter. All these cases
consisted of aggregates of epithelial structures (round to oval or
tadpole-like) that were dispersed in the fibrous stroma (Fig. 3a, b).
The epithelial structures consisted of monomorphic cells with bland
nuclei. Some epithelial structures contained small cystic spaces that
were outlined by two layers of cuboidal and occasionally flattened
cells. The flattening of the inner cell lining was due to keratinisa-
tion of these cells. An eosinophilic cuticle lining the lumen was
occasionally observed. Some microcysts contained horn pearls.
Tracingcelllineagesinsyringomaoftheskin.UsingK77asanovel
specific marker for eccrine duct lineage, a previous study
10 recently
demonstrated that this tumour differentiated towards duct epi-
thelium of eccrine glands. We observed extensive staining of the
epithelial structures with antibodies to basal keratins K5 and K14
without exception (Fig. 3c). With the squamous keratin K10 anti-
body, variable numbers of epithelial structures were stained (Fig. 3c.
We observed keratin K19 staining in the inner lining of the epithelial
structures (Fig. 3c). K19 immunostaining was positive due to an
accumulation of these keratin intermediate filaments in the cyto-
plasm of glandular cells. However in agreement with previous data
10,
glandular keratins K8 and K18 were not found in these tumours.
Triple immunostaining (Fig. 3d) revealed K5- or K14-positive
progenitor cells in most epithelial structures with either focal epi-
dermoid or glandular differentiation, which was revealed by sequen-
tial staining for K5/14 with K10 or K19. SMA-immunostaining of
syringoma sections only stained the vascular structures (not shown).
Discussion
In this study, we used triple immunofluorescence to reveal the
cellular composition of these tumours
11,12. All cases from the total
10 cases of syringomatous adenoma of nipple as well as all cases
from the total 16 cases of syringoma of the skin showed the
identical triple immunofluorescence patterns specifically for each
entity. We developed a cell model of syringomas of the nipple and
the skin (Fig. 4) using the epithelial cell models of human breast
epithelium
13–15, eccrine gland ducts
10, and squamous epithelium
28
as a reference. We demonstrated that syringomas of the breast
nipple and the skin consist of epithelial structures containing
tumour cells that express the following key intermediate keratin
filaments: basal keratins K5/14 and probably keratin K17
29. These
K5/14-positive cells appeared to be the key players in these lesions
as they provided the progeny cells for the two lineages observed in
these tumours: the epidermal differentiation-specific K10-positive
cell lineage and the glandular/luminal K8/18- and K19-positive
cell lineage.
Interestingly, K5/14-positive tumour cells corresponded pheno-
typically to K5/14-positive normal counterpart cells of large nip-
ple ducts, the outer layer of the sweat gland duct
10 and the basal
layer of squamous epithelium
16 (Fig. 4). All the nipple tumours in
this study expressed basal keratins K5 and K14. Furthermore,
these tumours had a triple-negative phenotype
29–36.A l t h o u g h
triple-negative and of basal phenotype, all these lesions are known
to have an excellent prognosis and thus belong to recently
described entities of basal type tumours of the breast with a good
outcome
29–36.
Figure 3 | Syringoma of the skin. (a) and (b) HE staining shows the
typical patterns with round to oval or tadpole- like epithelial structures
dispersed in a fibrous stroma. Many epithelial structures contain small
cysticspaceslinedbytwolayersofcuboidalandoccasionallyflattenedcells.
Theepithelialstructures consistofmonomorphic cellswithbland-looking
nuclei. (c) Prototypic immunohistochemical results for syringoma of the
skinforbasalkeratinK5,squamouskeratinK10andkeratinK19.Nearlyall
the tumour cells stain for K5. Keratin K19 is specifically expressed in
luminal cuticles of the tumour cells. (d) Triple immunofluorescence
studies for the location of basal (K5, pink), squamous (K10, green), and
(K19, red) keratins in the tumour cells. The lower row shows a section of
thiscompositeimagedecomposedintosinglecoloursforK5,K10andK19.
This figure demonstrates the extensive expression of basal keratin 5
in tumour structures. The cells in the periphery are intensively
immunostained with K5 antibody. The antibody against K10 (green
channel) displays focal staining in most epithelial structures. Keratin 19
is expressed in the cytoplasm of luminal cells of a variety of epithelial
structures(redchannel).Thesetumoursdisplaycompletenegativityofthe
tumour cells for K8/18. Furthermore, these structures lack a myoepithelial
cell layer. Scale bars, 100 mm.
www.nature.com/scientificreports
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ferentiation in terms of the expression of glandular/luminal keratins
K8/18/19. Thus, syringomas of the skin displayed a lineage differ-
entiationcharacterisedbytheexpressionofkeratinK19.Thislineage
demonstrated sequential expression of basal keratin K5/14 and
glandular keratin K19, which provided evidence that K19-positive
luminal cells were derived from K5/14-positive progenitor cells.
Most importantly, these tumours completely lacked glandular kera-
tins K8/18. This expression pattern resembled cells that constitute
theinnermostlayersofeccrineglandducts(Fig.4c).Thesedatawere
similar to previous results
10, which suggested the histogenesis of
syringoma of the skin from eccrine duct cells, based on the express-
ion of a novel keratin K77.
Ourfindingsonsyringomaoftheskinwereinstarkcontrasttoour
findings on syringoma of the nipple. All the tumours of the nipple
studied here expressed glandular keratins K8/18. Triple immuno-
staining unravelled the gradual transition of K5/14-positive pro-
genitor cells to K8/18-positive glandular cells in these tumours. As
previously suggested by other groups, these keratins were the typical
intermediatekeratinfilamentsexpressedinnormalglandularcellsof
breastepithelium(Fig.4d)
16.Wepreviouslydemonstratedthatthese
cells are derived from K5/14-positive progenitor cells
13. Given the
similarities in both tumours between glandular cell lineage differ-
entiation and their putative counterpart lineage differentiation of
breast nipple duct and sweat gland duct, we propose that both
tumoursoriginatedfromK5/14-positivecellsfromeithersweatducts
or breast epithelium, having retained their organotypic glandular
differentiation.
A common feature of nipple and skin syringomas was the epi-
dermal differentiation-specific keratin K10 lineage in a variable
amount of tumour tissue. We have characterised the K10-positive
lineage from its initiation. We demonstrated that the develop-
mental process of K10-positive differentiation in syringomas from
both sites mirrored the transformation of K5/14-positive cells to
K10-positive cells. We rationalised with others
10 that this trans-
formation emulated the developmental process of the intradermal
portion of the eccrine sweat duct. Given that syringoma of the
nipple originated in the nipple duct epithelium, we propose that
squamous differentiation must be regarded as a metaplastic change
caused by the ability of emerging K5/14-positive tumour cells to
differentiate towards ontogenetically related epithelial tissue, i.e.,
nipple epidermis
37 (Fig. 4).
Figure 4 | (a)CharacteristicstainingpatternsofK5andK10intheepidermis. (b)Schematicdrawingsofthedifferentiationlineagesofsyringomaofthe
skin (left) and syringoma of the nipple (right). The squamous differentiation resembles that of the differentiation of squamous cells from K5/14-
progenitor cells inthe basal layer of the epidermis. Glandular differentiation isdifferent inboth tumour types and resembles the skin sweat glandduct in
syringoma of the skin (c) and resembles the breast nipple duct in the syringoma of the nipple (d). (c) and (d) Red channel (Cy3) for K19, green channel
(Alexa Fluor-488) for K8/18 and pink (Alexa Fluor-647) for K5/14. Scale bar, 100 mm.
www.nature.com/scientificreports
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lineages found in these tumours.
In conclusion, we report that K5- and K14-positive tumour cells
represent the key players in syringoma of the nipple and the skin.
Furthermore, both tumour types showed an epidermal differenti-
ation-specifickeratin10-positivedifferentiation.Inskinsyringomas,
this phenomenon was akin to acrosyringial lineage differentiation of
the intra-epidermal eccrine duct
10. In syringomas of the nipple, this
phenomenonreflected thedifferentiation potentialoftheembryonic
rudiment breast epithelium derives from. Therefore, squamous cell
lineage differentiation of syringoma of the nipple can be regarded
as a true metaplasia, and its glandular differentiation appears to be
restricted to its organ specific developmental potential. Luminal
sweat duct differentiation was observed in syringoma of the skin
and breast duct epithelial differentiation in syringoma of the nipple.
Our results identified K5/14-positive cells of the breast nipple ducts
as the putative origin cells for syringomas of the nipple with the
glandular ddifferentiation of this tumour reflecting the organotypic
differentiation potential of this gland.
Methods
Human tissue source. Tissue probes were retrieved from the files of the Institute of
Pathology of the University of Mu ¨nster, the Reference and Consultation Centre of
Gynaecology and Breast Pathology as well as the Institute of Dermatopathology. The
patientswerefrom43to70yearsofage.Thecasesofsyringomaofthenipplehadbeen
seen in consultation at the University of Muenster. The tumours were routinely fixed
in neutral formalin and embedded in paraffin. Histopathology of the nipple tumours
was reviewed independently by four pathologists (WB, ThL, HB, TJ), while the skin
syringomas were reviewed by three pathologists (WB, MR, TJ) with the criteria
described in the WHO breast tumour classification from 2003
38 and the WHO
classification of skin tumours
27. Normal human breast tissues obtained from plastic
surgery and normal skin with eccrine glands were used as controls.
Tissue probe processing and primary antibodies. For paraffin embedding, tissue
probes were routinely fixed with 4% formaldehyde in PBS, pH 7.4. PBS was used for
all washes and dilutions. Paraffin tissue sections (4 mm thick) were deparaffinised
with xylene and graded ethanol, while antigen retrieval was achieved by heating the
sections in 10 mM sodium citrate buffer, pH 6.0, at 95uC for 30 min in a domestic
vegetable steamer. Immunostaining was performed according to the standard
protocol routinely used for immunohistopathology
11. We recently reported that
endogenous Fc receptors in routinely fixed cells and tissue probes do not retain their
ability to bind Fc fragments of antibodies
39; therefore, blocking the endogenous Fc
receptors prior to incubation with primary antibodies was omitted. Antibodies were
applied according to manufacturers’ recommendations. The final concentration of
primaryantibodieswas1to5 mg/mlinPBS,andthefinalconcentrationofsecondary
antibodies was 5 to 10 mg/ml in PBS. For immunostaining, we used primary
antibodies raised against keratin 5 (rabbit monoclonal, MEDAC Diagnostica),
keratins K5/6, 7, 10, 14, 18, 18/19, and 8/18/19 (mouse monoclonal, DAKO, Sigma
and Dianova), a-smooth muscle actin (SMA; rabbit polyclonal, Abcam), vimentin
(Abcam and DAKO), Bcl2 (DAKO). The exclusion of the primary antibody from the
immunohistochemical reaction or substitution of primary antibodies with normal
IgG (mouse or rabbit) at the same final concentration as that of primary antibodies
resulted in a lack of immunostaining.
Bright-field microscopy. After immunoreactions with primary antibodies, the
sections were treated for 10 min with methanol containing 0.6% H2O2 to quench
endogenousperoxidase.Forbright-fieldmicroscopy,boundprimaryantibodies were
detected with Dako LSAB REAL Detection System (Naphthol phosphate/Fast Red,
#K5005, Dako Corporation, Hamburg, Germany) or with AmpliStain
TM Horse
Radish Peroxidase (HRP) conjugate (SDT GmbH, Baesweiler, Germany), according
to manufacturers’ instructions. The HRP label was visualised using NovaRed
substrate kit (Vector Laboratories, Burlingame, CA, USA). The sections were
counterstained with haematoxylin. All steps were preceded by rinsing with PBS
(pH 7.4).
Multiple fluorescence immunolabelling. For fluorescence microscopy, we used
secondary antibodies (purchased from Dianova and Molecular Probes) conjugated
with Cy3, Alexa Fluor-488, Alexa Fluor-647 or biotin. For double and triple
immunostaining, we used secondary antibodies raised against corresponding IgG
species or corresponding IgG isotype
11,12. For simultaneous visualisation of primary
antibodies of the same IgG isotype, primary antibodies were non-covalently labelled
with a reporter molecule in vitro, which employed monovalent IgG Fc-specific Fab
fragments according to previous literature
40. The reporter molecule was either
fluorophore Cy3 or biotin. The latter was visualised using fluorophore-labelled
streptavidin.NucleiwerecounterstainedwithDAPI(5 mg/mlPBS,15s),andsections
were mounted with VectaShield (Vector Laboratories, Burlingame, USA).
Image acquisition. Immunostained sections were examined on a Zeiss microscope
‘‘Axio Imager Z1’’. Microscopy images were captured using AxioCam digital
microscopecamerasandAxioVisionimageprocessing(CarlZeissVision,Germany).
The images were acquired at 96 DPI and submitted with the final revision of the
manuscript at 300 DPI.
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